Document And Entity Information
Document And Entity Information | Feb. 29, 2024 |
Document Information [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Feb. 29, 2024 |
Entity Registrant Name | Renalytix plc |
Entity Central Index Key | 0001811115 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Securities Act File Number | 001-39387 |
Entity Incorporation, State or Country Code | X0 |
Entity Tax Identification Number | 00-0000000 |
Entity Address, Address Line One | Finsgate |
Entity Address, Address Line Two | 5-7 Cranwood Street |
Entity Address, City or Town | London EC1V 9EE |
Entity Address, Country | GB |
Entity Address, Postal Zip Code | EC1V 9EE |
City Area Code | +44 |
Local Phone Number | 20 3139 2910 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Ordinary shares, nominal value £0.0025 per ordinary share |
No Trading Symbol Flag | true |
Security Exchange Name | NASDAQ |
American Depositary Shares [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | American Depositary Shares, each representing two ordinary shares, nominal value £0.0025 per ordinary share |
Trading Symbol | RNLX |
Security Exchange Name | NASDAQ |